Eosinophilic Esophagitis
Eosinophilic esophagitis associated with increased number, severity of food allergies
Patients with food allergies and eosinophilic esophagitis have more food allergies, more allergic reactions and increased reaction severity, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Evolving Treatment Landscape of EoE: Applying the Latest Evidence to Optimize Care
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc & Sanofi.
Atopic, allergic comorbidities prevalent among patients with eosinophilic esophagitis
SAN ANTONIO — A high proportion of patients with eosinophilic esophagitis also had simultaneous atopic or allergic comorbid conditions, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Milk elimination achieves similar histological remission vs. more restrictive diet in EoE
The elimination of animal milk alone was an effective first step in dietary therapy for patients with eosinophilic esophagitis, according to research published in The Lancet Gastroenterology & Hepatology.
Allergen immunotherapy shows promise for eosinophilic esophagitis
SAN ANTONIO — Allergen immunotherapy helped to relieve eosinophilic esophagitis symptoms and led to remission, according to results of a systematic review presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
FDA 2022 Rewind: GI drug pipeline rattles as FDA delivers 7 new drugs, 1 costly rejection
Gastroenterology had a big year in 2022, with potentially game-changing FDA approvals for inflammatory bowel disease and several first-in-class therapies, yet the FDA’s rejection of the first hepatitis D therapy still looms large.
Dupilumab improves eosinophilic esophagitis outcomes through 52 weeks
Weekly subcutaneous doses of dupilumab improved histologic outcomes and alleviated symptoms for adults and adolescents with eosinophilic esophagitis, according to a study published in The New England Journal of Medicine.
Gastrointestinal symptoms may indicate eosinophilic esophagitis among adults with atopy
The prevalence of eosinophilic esophagitis may be several times higher among patients with atopic disease than among the general population, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Food allergies, education take spotlight at ACAAI Annual Scientific Meeting
After working with the American College of Asthma, Allergy & Immunology for 3 decades, Kathleen May, MD, FACAAI, is excited to be taking its reins as president during its 2022 Annual Scientific Meeting, Nov. 10 to 14, in Louisville, Ky.
Dupixent maintains long-term safety, efficacy in patients with EoE
CHARLOTTE, N.C. — Dupilumab maintains its safety and efficacy for up to 52 weeks in patients with eosinophilic esophagitis, according to late-breaking data from the phase 3 LIBERTY EoE TREET study presented at ACG Annual Scientific Meeting.